The "Arthritis Monoclonal Antibodies Global Market Report 2022: By Drug, By Application, By End-Use" report has been added to ResearchAndMarkets.com's offering.
The "Conjugated Monoclonal Antibodies Global Market Report 2022: By Drugs, By Technology, By Application" report has been added to ResearchAndMarkets.com's offering.
The “Breast Cancer Monoclonal Antibodies Global Market Report 2022: By Product, By End-User” report has been added to ResearchAndMarkets.com’s offering. The global breast cancer monoclonal antibodies ...
The “Conjugated Monoclonal Antibodies Global Market Report 2022: By Drugs, By Technology, By Application” report has been added to ResearchAndMarkets.com’s offering. The global conjugated monoclonal ...
DUBLIN, June 22, 2022 /PRNewswire/ -- The "Breast Cancer Monoclonal ... therapy uses a treatment method in which a patient is given two or more drugs (or other therapeutic agents) for a single disease ...
Funding will enable the development of Spirea’s pipeline of antibody drug conjugate therapeutics for the treatment of solid tumours.
A recent review summarized the current knowledge and treatment paradigm of multiple myeloma, including recent advances and ...
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.
The high cost of conjugated monoclonal antibodies is anticipated to limit the growth of ... site-specific antibody-drug conjugate, ARX305 used for the treatment of CD70 positive cancers.
Funding of £2.4 million has been secured by Spirea Limited, to advance a new generation of antibody drug conjugate (ADC) ...
The market is expected to reach $11.64 billion in 2026 at a CAGR of 22.7%.The global bi-specific mabs market is expected to ...